Topical Skin Lipid Complex for Dogs with Atopic Dermatitis
Author Information
Author(s): Fujimura Masato, Nakatsuji Yoshinobu, Fujiwara Subaru, Rème Christophe, Gatto Hugues
Primary Institution: Fujimura Animal Allergy Hospital
Hypothesis
The study aims to evaluate the efficacy of topical skin lipid complex (SLC) in treating canine atopic dermatitis (AD).
Conclusion
Topical SLC application may provide therapeutic benefits in managing canine atopic dermatitis.
Supporting Evidence
- Significant reduction in CADESI-03 scores was observed at 6 weeks after treatment.
- Erythema showed the most improvement, with a 36.2% reduction at 6 weeks.
- Excoriation and alopecia subscores also significantly decreased after treatment.
- The lichenification subscore did not show significant improvement.
- One dog was excluded from data analysis due to increased pruritus at the start of the study.
Takeaway
The study tested a special lotion on dogs with itchy skin, and it helped make their skin feel better.
Methodology
Eight dogs with chronic atopic dermatitis were treated with a topical skin lipid complex twice weekly for 12 weeks, and their symptoms were assessed using the CADESI-03 scale.
Potential Biases
Potential bias due to the open-label design and lack of blinding.
Limitations
The study was small and lacked a control group, and the treatment was not used as monotherapy.
Participant Demographics
Dogs aged 2-12 years, with a mean age of 6.75 years; included 2 female dogs, 5 spayed female dogs, and 1 castrated male dog.
Statistical Information
P-Value
P < 0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website